Targeting heat shock response in osteosarcoma cells by combination treatment / Dr. Alyaa R Mahmood Al- Khateeb … [et al.]

• Main Authors: Mahmood Al- Khateeb, Alyaa R, Froemming, Gabriele Ruth Anisah, Mohd Ismail, Aletza, Abdul Hamid Hasani, Narimah
• Format: Research Reports
• Language: English
• Published: Research Management Institute (RMI) 2013
• Subjects: RC0254 Neoplasms. Tumors. Oncology (including Cancer)
• Online Access: https://ir.uitm.edu.my/id/eprint/26751/1/LP_ALYAA%20R%20MAHMOOD%20AL-%20KHATEEB%20RMI%2013_5.pdf; https://ir.uitm.edu.my/id/eprint/26751/

Metformin has anticancer effects by inhibiting glucose metabolism. Hyperthermia sensitizes cancer cells. It is known that both metformin,hypo- and hyperthermia deregulate mitochondrial metabolism in cancer. However, the mechanism of the additive effect is not known. The combined effect of metformin and hypo- or hyperthermia on osteosarcoma cell line (MG-63 cell) viability, DNA damage, glucose metabolism, regulation of apoptotic genes and proteins were investigated. Osteosarcoma (MG-63) cells were treated with metformin IC50 30M for 48h followed by exposure to 45°C, 39°C, 35°C 27°C for 30 min, 1h and 2h , 37°C was served as control. The combinations of metformin with hypo- and hyperthermia significantly downregulated the expression of AKT1 and GSK3(3 genes, which led to a reduce cells viability and an increase in DNA damage. Metformin induced apoptosis and necrosis. The combined effect caused a downregulation of anti-apoptotic Bcl-2. The intrinsic pathway was not activated. Therefore, this study suggests that the combination of metformin with hyperthermia particularly 45°C, enhances apoptosis via Bax/Bid-dependent pathway.